{"text": ["Is", "Amgen", "Inc.", "a", "Buy?"], "created_at": "2018-02-21 16:10:52"}
{"text": ["Is", "Amgen", "Inc.", "a", "Buy?"], "created_at": "2018-02-21 16:10:52"}
{"text": ["Teva's", "Problems", "Continue", "to", "Mount", "With", "No", "Relief", "in", "Sight"], "created_at": "2018-02-21 15:12:44"}
{"text": ["Teva's", "Problems", "Continue", "to", "Mount", "With", "No", "Relief", "in", "Sight"], "created_at": "2018-02-21 15:12:44"}
{"text": ["ACZ885:", "A", "Robust", "Treatment", "Option", "for", "Reducing", "Cardiovascular", "Risk?"], "created_at": "2018-02-21 14:03:21"}
{"text": ["Analysts\u2019", "Recommendations", "for", "GlaxoSmithKline", "after", "4Q17", "Earnings"], "created_at": "2018-02-21 14:01:39"}
{"text": ["Novartis", "Plans", "to", "Expand", "its", "Multiple", "Sclerosis", "Portfolio", "in", "2018"], "created_at": "2018-02-21 12:35:58"}
{"text": ["How", "Did", "JNJ\u2019s", "Vision", "Care", "Segment", "Perform", "in", "4Q17", "and", "2017?"], "created_at": "2018-02-21 12:33:10"}
{"text": ["Novartis", "Expects", "FDA", "and", "EMA", "Approvals", "for", "Aimovig", "in", "2018"], "created_at": "2018-02-21 12:31:44"}
{"text": ["The", "Swiss", "Stock", "Market", "Inched", "Higher", "As", "Heavyweights", "Underperform"], "created_at": "2018-02-21 12:09:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Inched", "Higher", "As", "Heavyweights", "Underperform"], "created_at": "2018-02-21 12:09:00"}
{"text": ["[$$]", "Novartis", "CEO", "Steers", "Drug", "Maker", "Back", "to", "R&D"], "created_at": "2018-02-21 04:33:52"}
{"text": ["Novartis", "Bribery", "Case", "in", "Greece", "Threatens", "to", "Bolster", "Populists"], "created_at": "2018-02-21 03:00:00"}
